Ricevi le ultime notizie sulle azioni Journey Medical con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di DERM

Ultime notizie per

JOURNEY MEDICAL CORP

Journey Medical

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

wall street chart shutter2

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

ALMS

CMRX

DERM

Analisi dei segnali di allarme nel settore sanitario: cosa rivela l&#39;indicatore tecnico chiave per gli investitori. È il momento di agire?

3 titoli del settore sanitario che potrebbero crollare nel secondo trimestre

Journey Medical Corporation - Common Stock

Journey Medical Corp

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics Inc

DermTech Inc

DermTech Inc Warrants(20/06/2022)

Dermapharm Holding SE

Dermisonics Inc

Health Care

Press Releases

General

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

Earnings

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Present at the Emerging Growth Conference

Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

Journey Medical Corporation to Participate in September 2025 Investor Conferences

Journey Medical Corporation to Participate in October 2025 Investor Conferences

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

ADVM

CLNN

CSE:METG

CSE:TCEC

CUAUF

EHGO

ELRRF

FBIO

FUFU

GOVX

GROV

HDRSF

HSCS

IMRN

JAGX

KBRIF

KPGHF

LGCXF

MGSTF

NCSM

NTRB

OMEX

OPWEF

PHXHF

PUMXF

RGBP

SRGZ

TCEFF

TSX:ELO

TSX:VGZ

TSXV:CCCM

TSXV:HI

TSXV:KRI

TSXV:LG

TSXV:OPW

TSXV:PUMA

TSXV:UCU

TSXV:VROY

USEG

UURAF

VROYF

XXII

Aardvark Therapeutics, Inc. - Common Stock

Aardvark Therapeutics

Aurora Cannabis

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

Bioage Labs

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cardiol Therapeutics Inc. - Class A Common Shares

Cardiol Therapeutics

Contineum Therapeutics, Inc. - Common stock

Contineum Therapeutics

Cybin

High Tide

Incannex Healthcare

LB Pharmaceuticals

MediWound

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals

NeOnc Technologies Holdings, Inc. - Common Stock

NeOnc Technologies Hldgs

Organigram Global

Pliant Therapeutics

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Cassava Sciences

Scilex Holding

Sol-Gel Technologies Ltd. - Ordinary Shares

Sol-Gel Technologies

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

Turn Therapeutics

Zhengye Biotechnology Holding Limited - Ordinary Shares

Zhengye Biotechnology

HC Wainwright & Co.

Lake Street

B. Riley Securities

Rodman & Renshaw

Roth MKM

Comments

Journey Medical Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO